Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 4 |
2015 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Molecular pathways: targeting NRAS in melanoma and acute myelogenous leukemia.
Clin Cancer Res. 2014 Aug 15;20(16):4186-92. doi: 10.1158/1078-0432.CCR-13-3270. Epub 2014 Jun 3.
Clin Cancer Res. 2014.
PMID: 24895460
Free PMC article.
Review.
Amuvatinib has cytotoxic effects against NRAS-mutant melanoma but not BRAF-mutant melanoma.
Fedorenko IV, Fang B, Koomen JM, Gibney GT, Smalley KS.
Fedorenko IV, et al.
Melanoma Res. 2014 Oct;24(5):448-53. doi: 10.1097/CMR.0000000000000103.
Melanoma Res. 2014.
PMID: 24950457
Free PMC article.
Item in Clipboard
XL888 Limits Vemurafenib-Induced Proliferative Skin Events by Suppressing Paradoxical MAPK Activation.
Phadke M, Gibney GT, Rich CJ, Fedorenko IV, Chen YA, Kudchadkar RR, Sondak VK, Weber J, Messina JL, Smalley KSM.
Phadke M, et al.
J Invest Dermatol. 2015 Oct;135(10):2542-2544. doi: 10.1038/jid.2015.205. Epub 2015 Jun 3.
J Invest Dermatol. 2015.
PMID: 26039542
Free PMC article.
No abstract available.
Item in Clipboard
The Novel ATP-Competitive MEK/Aurora Kinase Inhibitor BI-847325 Overcomes Acquired BRAF Inhibitor Resistance through Suppression of Mcl-1 and MEK Expression.
Phadke MS, Sini P, Smalley KS.
Phadke MS, et al.
Mol Cancer Ther. 2015 Jun;14(6):1354-64. doi: 10.1158/1535-7163.MCT-14-0832. Epub 2015 Apr 14.
Mol Cancer Ther. 2015.
PMID: 25873592
Free PMC article.
Item in Clipboard
Inhibition of HSP90 by AT13387 delays the emergence of resistance to BRAF inhibitors and overcomes resistance to dual BRAF and MEK inhibition in melanoma models.
Smyth T, Paraiso KHT, Hearn K, Rodriguez-Lopez AM, Munck JM, Haarberg HE, Sondak VK, Thompson NT, Azab M, Lyons JF, Smalley KSM, Wallis NG.
Smyth T, et al.
Mol Cancer Ther. 2014 Dec;13(12):2793-2804. doi: 10.1158/1535-7163.MCT-14-0452. Epub 2014 Oct 27.
Mol Cancer Ther. 2014.
PMID: 25349308
Free PMC article.
Item in Clipboard
Vertical inhibition of the MAPK pathway enhances therapeutic responses in NRAS-mutant melanoma.
Rebecca VW, Alicea GM, Paraiso KH, Lawrence H, Gibney GT, Smalley KS.
Rebecca VW, et al.
Pigment Cell Melanoma Res. 2014 Nov;27(6):1154-8. doi: 10.1111/pcmr.12303. Epub 2014 Sep 1.
Pigment Cell Melanoma Res. 2014.
PMID: 25130256
Free PMC article.
Item in Clipboard
Cite
Cite